AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23038702 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 50)
Number of subjects: 96
Study 19301936 — intervention group
Group type: EXPERIMENTAL
Intervention: niacin extended-release (NER) 500 mg/day in week 1, 1000 mg/day in week 2, and 2000 mg/day in weeks 3-6/aspirin (ASA)
Number of subjects: 276
Study 19301936 — intervention group
Group type: COMPARATOR
Intervention: NER/ASA placebo
Number of subjects: 276
Study 19301936 — intervention group
Group type: COMPARATOR
Intervention: NER placebo/ASA placebo
Number of subjects: 276
Study 17493057 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment methamphetamine use
Number of subjects: 420
Study 17493057 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender, route of administration, and pre-treatment methamphetamine use
Number of subjects: 420
Study 15448268 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology transfer condition with an interactive distance learning computer training curriculum and individualized distance consultation
Number of subjects: 42
Study 15448268 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 42
Study 11394684 — intervention group
Group type: EXPERIMENTAL
Intervention: High-level reasoning mechanism
Number of subjects: 0
Study 11394684 — intervention group
Group type: COMPARATOR
Intervention: Attention to distinctive input (ADIT)
Number of subjects: 0
Study 9722054 — intervention group
Group type: EXPERIMENTAL
Intervention: butorphanol (2 mg) + bupivacaine (0.25%)
Number of subjects: 109
Study 9722054 — intervention group
Group type: EXPERIMENTAL
Intervention: fentanyl (50 microg) + bupivacaine (0.25%)
Number of subjects: 109
Study 9722054 — intervention group
Group type: EXPERIMENTAL
Intervention: sufentanil (15 microg) + bupivacaine (0.25%)
Number of subjects: 109
Study 9722054 — intervention group
Group type: COMPARATOR
Intervention: saline + bupivacaine (0.25%)
Number of subjects: 109
Study 8051795 — intervention group
Group type: EXPERIMENTAL
Intervention: L-627 (biapenem) 6 mg/kg
Number of subjects: 297
Study 8051795 — intervention group
Group type: EXPERIMENTAL
Intervention: L-627 (biapenem) 12 mg/kg
Number of subjects: 297
Study 8051795 — intervention group
Group type: EXPERIMENTAL
Intervention: L-627 (biapenem) 5 mg/kg
Number of subjects: 297
Study 8051795 — intervention group
Group type: EXPERIMENTAL
Intervention: L-627 (biapenem) 20-40 mg/kg
Number of subjects: 297
Study 8051795 — intervention group
Group type: EXPERIMENTAL
Intervention: L-627 (biapenem)
Number of subjects: 297
Study 2923084 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg all‐rac‐alpha‐tocopherol and RRR‐gamma‐tocopherol
Number of subjects: 2
Study 2923084 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-gall bladder surgery
Number of subjects: 2
Study 4913784 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine
Number of subjects: 94
Study 4913784 — intervention group
Group type: COMPARATOR
Intervention: Pethidine
Number of subjects: 94
Study 30878507 — intervention group
Group type: EXPERIMENTAL
Intervention: Gloves-first technique
Number of subjects: 0
Study 30878507 — intervention group
Group type: COMPARATOR
Intervention: Closed staff-assisted technique
Number of subjects: 0
Study 30878507 — intervention group
Group type: COMPARATOR
Intervention: Open staff-assisted technique
Number of subjects: 0
Study 30878507 — intervention group
Group type: COMPARATOR
Intervention: Closed and open techniques
Number of subjects: 0
Study 28532478 — intervention group
Group type: EXPERIMENTAL
Intervention: 40ml High Volume Image Guided Injection (HVIGI) with or without corticosteroid
Number of subjects: 96
Study 28532478 — intervention group
Group type: COMPARATOR
Intervention: 3ml local anaesthetic sham-control injection
Number of subjects: 96
Study 25399017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model for cardiovascular mortality
Number of subjects: 5378
Study 25399017 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model for all-cause mortality
Number of subjects: 5378
Study 23219175 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent snoring
Number of subjects: 42244
Study 21529957 — intervention group
Group type: EXPERIMENTAL
Intervention: pegaptanib 0.3 mg
Number of subjects: 260
Study 21529957 — intervention group
Group type: COMPARATOR
Intervention: sham
Number of subjects: 260
Study 19732281 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (154 mEq/L)
Number of subjects: 93
Study 19732281 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride (0.9%) and oral N-acetylcysteine (NAC)
Number of subjects: 93
Study 22905595 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment with high-dose hypoallergenic 6-grass pollen preparation (SCIT)
Number of subjects: 37
Study 22905595 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 37
Study 15828937 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharp debridement
Number of subjects: 55
Study 15828937 — intervention group
Group type: COMPARATOR
Intervention: Control (minimal granulation tissue)
Number of subjects: 55
Study 12451325 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil 180 mg/day + Trandolapril 2 mg/day
Number of subjects: 29
Study 12451325 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg/day + Nifedipine 20 mg/day
Number of subjects: 29
Study 12451325 — intervention group
Group type: COMPARATOR
Intervention: Control group (11 normotensive subjects)
Number of subjects: 29
Study 9710002 — intervention group
Group type: EXPERIMENTAL
Intervention: LBV
Number of subjects: 188
Study 9710002 — intervention group
Group type: COMPARATOR
Intervention: AD
Number of subjects: 188
Study 7874893 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental formula (Impact) supplemented with arginine, nucleotides, and fish oil
Number of subjects: 296
Study 7874893 — intervention group
Group type: COMPARATOR
Intervention: Common use control formula (Osmolite.HN)
Number of subjects: 296
Study 7874893 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental formula (Impact)
Number of subjects: 296
Study 2172178 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fibre supplement (7 g/day)
Number of subjects: 52
Study 2172178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 292718 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide‐oxygen
Number of subjects: 20
Study 292718 — intervention group
Group type: COMPARATOR
Intervention: Oxygen
Number of subjects: 20
Study 30477789 — intervention group
Group type: EXPERIMENTAL
Intervention: Telotristat ethyl (TE) 250 mg TID
Number of subjects: 135
Study 30477789 — intervention group
Group type: EXPERIMENTAL
Intervention: Telotristat ethyl (TE) 500 mg TID
Number of subjects: 135
Study 30477789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 135
Study 30477789 — intervention group
Group type: EXPERIMENTAL
Intervention: Telotristat ethyl (TE) 500 mg TID in open-label extension (OLE)
Number of subjects: 135
Study 30477789 — intervention group
Group type: EXPERIMENTAL
Intervention: Durable responders (DRs) during the DBTP
Number of subjects: 135
Study 27426426 — intervention group
Group type: EXPERIMENTAL
Intervention: Health-led FRIENDS intervention
Number of subjects: 1362
Study 27426426 — intervention group
Group type: COMPARATOR
Intervention: School-led FRIENDS intervention
Number of subjects: 1362
Study 27426426 — intervention group
Group type: COMPARATOR
Intervention: Usual PSHE lessons
Number of subjects: 1362
Study 25701700 — intervention group
Group type: EXPERIMENTAL
Intervention: 4.375 g/day gluten
Number of subjects: 61
Study 25701700 — intervention group
Group type: COMPARATOR
Intervention: Rice starch (placebo)
Number of subjects: 61
Study 23373881 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone
Number of subjects: 111
Study 23373881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 20575400 — intervention group
Group type: EXPERIMENTAL
Intervention: Sheshiliuhuang decoction, 2 times a day for 7 days
Number of subjects: 92
Study 20575400 — intervention group
Group type: COMPARATOR
Intervention: Sanjin pills, 3 pills 3 times a day for 7 days
Number of subjects: 92
Study 19090322 — intervention group
Group type: EXPERIMENTAL
Intervention: APD125 10 mg
Number of subjects: 173
Study 19090322 — intervention group
Group type: EXPERIMENTAL
Intervention: APD125 40 mg
Number of subjects: 173
Study 19090322 — intervention group
Group type: EXPERIMENTAL
Intervention: APD125
Number of subjects: 173
Study 19090322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 173
Study 15980934 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon calcitonin 200 IU/day for 2 months
Number of subjects: 35
Study 15980934 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol 1500 mg/day for 2 months
Number of subjects: 35
Study 12803872 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivermectin (200 mug/kg) alone
Number of subjects: 42
Study 12803872 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg) alone
Number of subjects: 42
Study 12803872 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of ivermectin and albendazole
Number of subjects: 42
Study 12803872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 10824236 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT (2 mg estradiol valerate and 1 mg cyproterone acetate)
Number of subjects: 464
Study 10824236 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 464
Study 10824236 — intervention group
Group type: EXPERIMENTAL
Intervention: HRT
Number of subjects: 464
Study 8667486 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Doppler imaging
Number of subjects: 21
Study 8667486 — intervention group
Group type: COMPARATOR
Intervention: Color Doppler imaging
Number of subjects: 21
Study 8667486 — intervention group
Group type: EXPERIMENTAL
Intervention: Neither modality
Number of subjects: 21
Study 1893709 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive use before pregnancy
Number of subjects: 846
Study 1893709 — intervention group
Group type: COMPARATOR
Intervention: Oral contraceptive use in early pregnancy
Number of subjects: 846
Study 7049588 — intervention group
Group type: EXPERIMENTAL
Intervention: Proglumetacin (300 mg daily in two divided doses)
Number of subjects: 40
Study 7049588 — intervention group
Group type: COMPARATOR
Intervention: Naproxen (500 mg daily in two divided doses)
Number of subjects: 40
Study 31563536 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted sacrocolpopexy
Number of subjects: 100
Study 31563536 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic sacrocolpopexy
Number of subjects: 100
Study 29470389 — intervention group
Group type: EXPERIMENTAL
Intervention: Walnut-enriched diet (43 g/day)
Number of subjects: 194
Study 29470389 — intervention group
Group type: COMPARATOR
Intervention: Control diet (nut-free diet)
Number of subjects: 194
Study 27246468 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine (AA)
Number of subjects: 609
Study 27246468 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 609
Study 27246468 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DHP)
Number of subjects: 609
Study 25339455 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 200
Study 25339455 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 200
Study 22678562 — intervention group
Group type: EXPERIMENTAL
Intervention: Low glycaemic load diet
Number of subjects: 32
Study 22678562 — intervention group
Group type: COMPARATOR
Intervention: Control group diet
Number of subjects: 32
Study 19924114 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta‐9‐THC
Number of subjects: 15
Study 19924114 — intervention group
Group type: COMPARATOR
Intervention: CBD
Number of subjects: 15
Study 18188658 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (two one-hour exercise sessions per week for 20 weeks with a trained physiotherapist)
Number of subjects: 98
Study 18188658 — intervention group
Group type: COMPARATOR
Intervention: Control group (receiving no intervention)
Number of subjects: 98
Study 16025052 — intervention group
Group type: EXPERIMENTAL
Intervention: Evac tonsillectomy
Number of subjects: 17
Study 16025052 — intervention group
Group type: COMPARATOR
Intervention: Bovie tonsillectomy
Number of subjects: 17
Study 12436013 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 88
Study 12436013 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational Therapy (PET)
Number of subjects: 88
Study 12436013 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CBT and PET
Number of subjects: 88
Study 12029990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 5640
Study 12029990 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin (low dose, 5 mg/day)
Number of subjects: 5640
Study 12029990 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (5 to 10 mg/day for 6 years)
Number of subjects: 5640
Study 9857636 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (6 x 2 Gy using 6 MV photons)
Number of subjects: 76
Study 9857636 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 76
Study 8934955 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 0
Study 8934955 — intervention group
Group type: COMPARATOR
Intervention: 5% lidocaine
Number of subjects: 0
Study 2693916 — intervention group
Group type: EXPERIMENTAL
Intervention: Oestrogen-progestogen replacement therapy for 12 months
Number of subjects: 57
Study 2693916 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 57
Study 447801 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (100 mg)
Number of subjects: 6
Study 447801 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone enanthate (400 mg)
Number of subjects: 6
Study 447801 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 6
Study 31591706 — intervention group
Group type: COMPARATOR
Intervention: Single injection of PPD (n=29)
Number of subjects: 66
Study 31591706 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple injections of PPD (n=29)
Number of subjects: 66
Study 28097515 — intervention group
Group type: EXPERIMENTAL
Intervention: Early palliative care
Number of subjects: 350
Study 25713937 — intervention group
Group type: EXPERIMENTAL
Intervention: Rule 4901 (residential wood-burning regulation)
Number of subjects: 2
Study 23799166 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblation tonsillectomy
Number of subjects: 80
Study 23799166 — intervention group
Group type: COMPARATOR
Intervention: Electrocautery tonsillectomy
Number of subjects: 80
Study 21849730 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal work hardening (MWH)
Number of subjects: 236
Study 21849730 — intervention group
Group type: COMPARATOR
Intervention: Conventional musculoskeletal rehabilitation (controls)
Number of subjects: 236
Study 19487505 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment (standard decompressive laminectomy with or without fusion)
Number of subjects: 607
Study 19487505 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative care
Number of subjects: 607
Study 17925539 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (n = 19,541), goal to reduce total fat intake to 20% of energy and increase consumption of vegetables, fruits, and grains.
Number of subjects: 48835
Study 17925539 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern intervention (n = 19,541)
Number of subjects: 48835
Study 17925539 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (usual diet; n = 29,294)
Number of subjects: 48835
Study 15482766 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E(2) 50 microg/24 hours
Number of subjects: 21
Study 15482766 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E(2) 75 microg/24 hours
Number of subjects: 21
Study 15482766 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal E(2) 100 microg/24 hours
Number of subjects: 21
Study 15482766 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 11172837 — intervention group
Group type: EXPERIMENTAL
Intervention: ICSI
Number of subjects: 35
Study 11172837 — intervention group
Group type: COMPARATOR
Intervention: Conventional IVF
Number of subjects: 35
Study 9155575 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic beverages produced by fermentation (beer, wine, champagne, martini, sherry)
Number of subjects: 16
Study 9155575 — intervention group
Group type: COMPARATOR
Intervention: Distilled alcoholic beverages (whisky, cognac, calvados, armagnac, rum)
Number of subjects: 16
Study 9155575 — intervention group
Group type: EXPERIMENTAL
Intervention: Distilled remaining parts of beer, wine, and sherry
Number of subjects: 16
Study 9155575 — intervention group
Group type: COMPARATOR
Intervention: Control (isotonic glucose and distilled water)
Number of subjects: 16
Study 7815840 — intervention group
Group type: EXPERIMENTAL
Intervention: ATRA (all-trans retinoic acid) treatment
Number of subjects: 0
Study 7815840 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive chemotherapy
Number of subjects: 0
Study 7815840 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose corticosteroids
Number of subjects: 0
Study 7815840 — intervention group
Group type: COMPARATOR
Intervention: Maintenance therapy
Number of subjects: 0
Study 2455141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine as a capsule with high sodium intake
Number of subjects: 0
Study 2455141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine as a tablet with high sodium intake
Number of subjects: 0
Study 2455141 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine with addition of a thiazide diuretic for 1 month
Number of subjects: 0
Study 29866147 — intervention group
Group type: EXPERIMENTAL
Intervention: Actitan F and standard oral rehydration (SOR)
Number of subjects: 60
Study 29866147 — intervention group
Group type: COMPARATOR
Intervention: Standard oral rehydration (SOR) only
Number of subjects: 60
Study 26518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Active CPAP
Number of subjects: 1105
Study 26518698 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 1105
Study 26518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Belief in receiving active CPAP
Number of subjects: 1105
Study 26518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age
Number of subjects: 1105
Study 26518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of cardiovascular disorders
Number of subjects: 1105
Study 26518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of anxiety
Number of subjects: 1105
Study 26518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of nasal congestion
Number of subjects: 1105
Study 26518698 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence during the week prior to a clinic visit
Number of subjects: 1105
Study 24781035 — intervention group
Group type: COMPARATOR
Intervention: Standard Management (SM)
Number of subjects: 167
Study 24781035 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulodexide
Number of subjects: 167
Study 24781035 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 167
Study 22561556 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri NCIMB 30242 capsules (n=67)
Number of subjects: 131
Study 22561556 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules (n=64)
Number of subjects: 131
Study 20054544 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (1 g as a 100 ml solution infused over 15 min, 1 h before anesthesia induction and then at 6-h intervals for 24 h)
Number of subjects: 124
Study 20054544 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 124
Study 20054544 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study 20054544 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol and Placebo
Number of subjects: 124
Study 18403876 — intervention group
Group type: EXPERIMENTAL
Intervention: Softliner material
Number of subjects: 17
Study 18403876 — intervention group
Group type: EXPERIMENTAL
Intervention: Soft lining materials
Number of subjects: 17
Study 18403876 — intervention group
Group type: EXPERIMENTAL
Intervention: Time periods (days 1, 7, and 14)
Number of subjects: 17
Study 18403876 — intervention group
Group type: COMPARATOR
Intervention: Acrylic resin
Number of subjects: 17
Study 15784021 — intervention group
Group type: EXPERIMENTAL
Intervention: EVL plus propranolol
Number of subjects: 144
Study 15784021 — intervention group
Group type: COMPARATOR
Intervention: EVL alone
Number of subjects: 144
Study 15656359 — intervention group
Group type: EXPERIMENTAL
Intervention: PPCIOL
Number of subjects: 43
Study 15656359 — intervention group
Group type: COMPARATOR
Intervention: Lasik
Number of subjects: 43
Study 11004028 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (2.25 ng/mL) in awake subjects
Number of subjects: 7
Study 11004028 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (2.25 ng/mL) in anesthetized subjects
Number of subjects: 7
Study 8630718 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 28
Study 8630718 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 1609533 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Tramadol (Tramal)
Number of subjects: 66
Study 1609533 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg Tramadol (Tramal) and 10 mg Triflupromazine (Psyquil)
Number of subjects: 66
Study 1609533 — intervention group
Group type: COMPARATOR
Intervention: 50 mg Pethidine (Alodan) and 10 mg Triflupromazine (Psyquil)
Number of subjects: 66
Study 1609533 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of analgesic with antiemetic
Number of subjects: 66
Study 6375285 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral pretreatment with verapamil for one week
Number of subjects: 0
Study 6375285 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-hour iv infusion of verapamil
Number of subjects: 0
Study 6375285 — intervention group
Group type: COMPARATOR
Intervention: Oral glibenclamide therapy
Number of subjects: 0
Study 6375285 — intervention group
Group type: EXPERIMENTAL
Intervention: iv infusion of verapamil
Number of subjects: 0